Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review

The management of diabetes and renal failure is changing thanks to the appearance of new drugs such as glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter type 2 inhibitors (SGLT2i) that have benefits in terms of survival and cardiorenal protection. Based on the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Valencia-Morales, Nancy Daniela, Rodríguez-Cubillo, Beatriz, Loayza-López, Rómulo Katsu, Moreno de la Higuera, Maria Ángeles, Sánchez-Fructuoso, Ana Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304316/
https://www.ncbi.nlm.nih.gov/pubmed/37374048
http://dx.doi.org/10.3390/life13061265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304316/
https://www.ncbi.nlm.nih.gov/pubmed/37374048
http://dx.doi.org/10.3390/life13061265

Ejemplares similares